Allergy immunotherapy - recombinant technology

Focus of research

My research focuses on the development of next generation birch pollen immunotherapy. The main goals are improvement of the efficacy and reduction of side effects by using nano delivery systems and novel adjuvants to target the antigen presenting cells of the immune system. These cells have been shown to play a crucial role in establishing adaptive immunity and skewing an existing allergic Th2 response to a tolerant Th1/Treg response.